Monopar Therapeutics Inc

The current institutional shareholding score of Monopar Therapeutics Inc is 7.00, ranking 81 out of 389 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 88.03%, representing a quarter-over-quarter increase of 29.07%. The largest institutional shareholder is Bill Nygren | OAKMX, holding a total of 254.69 shares, representing 0.00% of shares outstanding, with 100.00% decrease in holdings.